Compare COO & RTO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | COO | RTO |
|---|---|---|
| Founded | 1980 | 1925 |
| Country | United States | United Kingdom |
| Employees | N/A | N/A |
| Industry | Ophthalmic Goods | Business Services |
| Sector | Health Care | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 16.1B | 15.0B |
| IPO Year | N/A | N/A |
| Metric | COO | RTO |
|---|---|---|
| Price | $84.34 | $31.03 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 11 | 2 |
| Target Price | ★ $88.55 | N/A |
| AVG Volume (30 Days) | ★ 2.9M | 634.8K |
| Earning Date | 12-04-2025 | 01-21-2026 |
| Dividend Yield | N/A | ★ 1.69% |
| EPS Growth | ★ N/A | N/A |
| EPS | ★ 1.87 | 0.13 |
| Revenue | $4,092,400,000.00 | ★ $7,581,860,530.00 |
| Revenue This Year | $6.56 | $47.48 |
| Revenue Next Year | $5.32 | $3.26 |
| P/E Ratio | ★ $44.25 | $225.45 |
| Revenue Growth | ★ 5.06 | N/A |
| 52 Week Low | $61.78 | $19.60 |
| 52 Week High | $100.24 | $30.23 |
| Indicator | COO | RTO |
|---|---|---|
| Relative Strength Index (RSI) | 66.90 | 71.19 |
| Support Level | $80.23 | $29.43 |
| Resistance Level | $83.64 | $30.11 |
| Average True Range (ATR) | 1.40 | 0.39 |
| MACD | -0.23 | 0.04 |
| Stochastic Oscillator | 97.88 | 83.88 |
CooperCompanies is one of the largest eyecare companies in the US. It operates in two segments: CooperVision and CooperSurgical. CooperVision is a pure-play contact lens business with a suite of spherical, multifocal, and toric contact lenses. The company also has one of the most comprehensive specialty lens portfolios in the world. With brands including Proclear, Biofinity, MyDay, and Clariti, Cooper controls roughly one fourth of the US contact lens market. CooperSurgical, founded in 1990, is made up of equipment related to reproductive care, fertility, and women's care. Cooper has the broadest medical device coverage of the entire IVF cycle. It also has Paragard, the only hormone-free IUD in the US, and controls 17% of the US IUD market.
Rentokil Initial is the largest global provider of route-based pest control and commercial hygiene services, operating in 89 countries, with its largest operations in the United States following the acquisition of Terminix. The group also offers a range of specialist route-based services, including office and commercial space plant care, property care, and workwear rentals. The group serves a diverse client base of global food producers, hotel chains, industrial goods companies, restaurants, and individual residential customers.